FindTrial
Sign In

To study the effect of Astaguna Manda and Jvarahara Phant Siddha Manda in jvara

A Clinical Coparative Study to Assess The Effectiveness of Astaguna Manda And Jvarahara Phanta Siddha Manda In Jvara

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/11/021927
Enrollment
40
Registered
2019-11-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B349- Viral infection, unspecified

Interventions

Intervention1: Astaguna Manda: Astaguna Manda will be administered to Jvara patients for 5-7 days and 2-3 times in a day dose according to appetite of the patient Control Intervention1: Jvarahara Phan

Sponsors

National institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of pyrexia who exhibits the temperature between 99-102â?¦F

Exclusion criteria

Exclusion criteria: pyrexia associated with the other complaints like nausea vomiting, diagnosed cases of becterial origin pyrexia, Life threatening complaints like Dengue Hemorrhagic Fever

Design outcomes

Primary

MeasureTime frame
Astaguna Manda May help to manage jvara and its symptomsTimepoint: 7 days after first patient register—

Secondary

MeasureTime frame
The patient will be more energetic and quality of life may become betterTimepoint: one month after one patient register—

Countries

India

Contacts

Public ContactVd Kashinath Samagandi

National Institute of Ayurveda Jaipur

kashisri@gmail.com7877444353

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026